IGM Biosciences
IGMS
$9.26
Share price
-2.32%
Change (1 day)
-20.52%
Change (1 year)
Categories
IGM Biosciences (IGMS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.22 B
According to IGM Biosciences's latest financial reports the company's total liabilities are $0.22 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
IGM Biosciences - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.22 B | -2.68% |
| 2022-12-31 | $0.22 B | 325.1% |
| 2021-12-31 | $53.21 M | 98.45% |
| 2020-12-31 | $26.81 M | 26.98% |
| 2019-12-31 | $21.11 M | -69.75% |
| 2018-12-31 | $69.8 M | 66.63% |
| 2017-12-31 | $41.89 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -87.32% | 🇺🇸 USA |